Cannabidivarin (CBDV) is a chemical in the Cannabis sativa plant. It is similar to cannabidiol (CBD). Like CBD, cannabidivarin does not affect thinking. Early research suggests that...

2019年8月5日 · CBDV, or cannabidivarin, is one of many molecules derived from cannabis and hemp plants. These molecules, commonly referred to as cannabinoids, are partially responsible for the many effects...

THE BEST OF THE BEST WIN ON CALIFORNIA SAND. JOIN THEM. BEAT THEM. Founded in 1962, the CBVA was created to bring together all levels of beach volleyball players to compete in high-quality tournaments along the California coast.

2023年11月23日 · Cerebrovascular diseases include stroke, transient ischemic attack (TIA), aneurysm, and vascular malformation. In this article, we explain the statistics, symptoms, types, and treatments for...

Cannabidivarin (CBDV) is a pharmacologically active compound found in cannabis. This minor cannabinoid was first isolated in 1969 and research uncovering its properties is still ongoing. CBDV has...

2006年1月1日 · Specific objectives were to: (1) determine risk factors for the presence of CBVD at baseline, (2) assess risk factors for the subsequent occurrence of cerebrovascular deaths, and (3) analyze the effects of dose and flux on cerebrovascular mortality.

Cardiovascular disease (CVD) and its risk factors (e.g., hypertension, diabetes, obesity) are known determinants of incident cognitive impairment and dementia [1] due to cerebrovascular disease (CBVD), Alzheimer’s disease (AD), and AD related dementias (ADRD) [2 – 29].

Vascular Cognitive Impairment (VCI) is the second most prevalent dementia after Alzheimer's Disease (AD), and cerebrovascular disease (CBVD) is a major comorbid contributor to the progression of most neurodegenerative diseases.

CBVD in Medical refers to a chemotherapy regimen consisting of Carmustine, Bleomycin, Vinblastine, and Dexamethasone, commonly used in the treatment of certain types of cancer. This combination aims to enhance the effectiveness of cancer treatment by targeting different cellular processes involved in tumor growth.

Five factors tentatively affecting cognitive function in patients with CAD were identified: coronary artery bypass grafting (CABG) surgery, apolipoprotein E4 (APOE4) genotype, left ventricular ejection fraction (LVEF), medication use, and various hormones and biomarkers.